Live Case from MedStar Washington Hospital Center | Washington, DC

Tuesday, February 28, 2023

10:40 AM – 11:30 AM ET

Live Case Operator(s)

Itsik Ben-Dor, MD

WHC
MedStar Washington Hospital Center
Washington, District of Columbia, United States

No relationships to disclose
Hayder D. Hashim, MD

Interventional Cardiologist
Medstar Washington Hospital Center/Georgetown University
washington, District of Columbia, United States

Disclosure(s): Abbott, Boston Scientific, CSI, Philips: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speakers' Bureau (Ongoing)

Moderator(s)

Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT

Catheterization Laboratory Director & Deputy Head of Cardiology
King Fahd Armed Forces Hospital
Jeddah, Makkah, Saudi Arabia

No relationships to disclose
Maurice Buchbinder, MD, FSCAI

Medical Director
Foundation for Cardiovascular Medicine
San Diego, California, United States

No relationships to disclose

Panel Discussant(s)

Amit Amin, MD (he/him/his)

Associate Professor of Medicine
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States

Disclosure(s): Chiesi: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); General Electric: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
H. Vernon Anderson, MD

Professor of Medicine
University of Texas Health Science Center
McGovern Medical School
Houston, Texas, United States

Disclosure(s): No financial relationships to disclose
Ravi Dave, MD

Director, Interventional Cardiology
UCLA Health
UCLA
Santa Monica, California, United States

No relationships to disclose
Joseph De Gregorio, MD

Executive Director Cardiovascular ServicesProfessor of Cardiology
Englewood Hospital and Medical CenterHackensack Meridian School of Medicine at Seton Hall university
Wyckoff, New Jersey, United States

No relationships to disclose
Edward Koifman, MD

Director Interventional Cardiology
Meir Medical Center, and Tel Aviv University, Israel
Tel Aviv , Tel Aviv, Israel

Disclosure(s): No financial relationships to disclose
ML

Michael S. Lee, MD, FACC, FSCAI

Interventional Cardiologist
UCLA School of Medicine
LOS ANGELES, California, United States

No relationships to disclose
Timir Paul, MD, PhD, FACC, FSCAI

Associate Professor. Program Director, Cardiovascular Disease Fellowship
University of Tennessee at Nashville, Ascension St. Thomas Hospital
Brentwood, Tennessee, United States

No relationships to disclose
Ramon Quesada, MD, FACP, FACC, FSCAI

Medical Director of Interventional Cardiology, Structural Heart & Cardiac Research
Miami Cardiac & Vascular Institute
Miami, Florida, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Hayder D. Hashim, MD: Abbott, Boston Scientific, CSI, Philips: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speakers' Bureau (Ongoing)

Amit Amin, MD: Chiesi: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); General Electric: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

H. Vernon Anderson, MD: No financial relationships to disclose

Edward Koifman, MD: No financial relationships to disclose

Sa'ar Minha, MD: Astra Zeneca: Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing); Boston Scientific: Advisor (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing); Medtronic Inc: Advisor (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing), Honoraria (Ongoing); Novartis: Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing); NovoNordisk: Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing); Pfizer: Advisor (Ongoing), Consultant/Advisory Board (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing); Philips: Consultant (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing); Renaly: Consultant (Ongoing); sanofi-aventis: Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing); Symbiosis: Advisor (Ongoing), Royalties (Ongoing)

Ramon Quesada, MD, FACP, FACC, FSCAI: No financial relationships to disclose